Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management.

Literature DB >> 21660410

A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management.

Michael Postow¹, Manish A Shah, Maeve Lowery, Ali Shamseddine, Aghiad El-Kutoubi, Ashwaq Al Olayan, Mohamed Naghy, Celina Ang, Sally Tamraz, Abdul-Rahman Jazieh, Eileen M O'Reilly, David P Kelsen, Ghassan K Abou-Alfa.

Abstract

Entities: Disease Species

Mesh：

Year: 2012 PMID： 21660410 DOI： 10.1007/s12029-011-9294-9

Source DB: PubMed Journal: J Gastrointest Cancer

Keyword Cloud
References

× No keyword cloud information.

21 in total

1. Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

Authors: Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Tamandl; Klaus Kaczirek; Rudolf Roka; Sandra Freimann-Pircher; Thomas Gruenberger
Journal: Lancet Oncol Date: 2010-11-09 Impact factor: 41.316

2. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors: A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal: Am J Gastroenterol Date: 2000-01 Impact factor: 10.864

3. Phase II study of erlotinib in patients with advanced biliary cancer.

Authors: Philip A Philip; Michelle R Mahoney; Cristine Allmer; James Thomas; Henry C Pitot; George Kim; Ross C Donehower; Tom Fitch; Joel Picus; Charles Erlichman
Journal: J Clin Oncol Date: 2006-07-01 Impact factor: 44.544

4. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

Authors: M A Tempero; E Uchida; H Takasaki; D A Burnett; Z Steplewski; P M Pour
Journal: Cancer Res Date: 1987-10-15 Impact factor: 12.701

5. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors: Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal: N Engl J Med Date: 2010-04-08 Impact factor: 91.245

6. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

Authors: H J Kim; M H Kim; S J Myung; B C Lim; E T Park; K S Yoo; D W Seo; S K Lee; Y I Min
Journal: Am J Gastroenterol Date: 1999-07 Impact factor: 10.864

A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management.

1. Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

2. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

3. Phase II study of erlotinib in patients with advanced biliary cancer.

4. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

5. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

6. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

Review 7. Klinefelter syndrome: clinical and molecular aspects.

8. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study.

9. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.

10. Cancer incidence in men with Klinefelter syndrome.